HIV drug side-effects to go under the microscope

The unforeseen health problems for long-term HIV sufferers due to their anti-retro viral drugs are to be examined as part of a €13.5m medical research funding drive.

State body the Health Research Board confirmed the project will be included alongside studies focusing on cancer, pneumonia, and the road to universal health insurance during a high-profile meeting yesterday.

Speaking at the Royal College of Physicians in Ireland in central Dublin, HRB chief executive Graham Love said the fund will be split between 36 studies into a range of health issues over the next five years.